Skip to content
healthcare.dev

ORENCIA

NDC 0003-2187, abatacept, injection, powder, lyophilized, for solution, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-2187
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125118
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2187 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABATACEPT250 mg/15mL

Pharmacologic classes

Decreased Cytokine Activity [PE]; Recombinant Fusion Proteins [CS]; Selective T Cell Costimulation Modulator [EPC]

Package NDCNDC-11Package
0003-2187-13000032187131 VIAL, SINGLE-USE in 1 CARTON (0003-2187-13) / 15 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0836c6ac-ee37-5640-2fed-a3185a0b16eb
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-2187

Use it

Look up 0003-2187 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-2187 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-2187. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.